Skip to content Skip to navigation

NINDS Clinical Trial Readiness for Rare Neurological and Neuromuscular Diseases (U01) PAR-16-020

National Institutes of Health
Funding Sponsor: 
National Institutes of Health
Contact Email: 
GrantsInfo@nih.gov
Funding Deadline: 
February 15, 2018 - 11:59 pm

NINDS Clinical Trial Readiness for Rare Neurological and Neuromuscular Diseases (U01) PAR-16-020

Purpose: This FOA invites researchers to submit applications for support of clinical projects that address critical needs for clinical trial readiness in rare neurological or neuromuscular diseases/conditions.  Components of trial readiness may include knowledge of the course of disease necessary for selecting cohorts of patients with defined characteristics, and validation of clinical outcome measures or biomarkers appropriate for assessing response to the intervention.  By supporting studies aimed at clinical trial readiness, the NINDS intends to accelerate the testing of candidate therapeutics and increase the likelihood of successful trials. 

Remaining deadlines:  Feb. 15, 2018; Aug. 17, 2018

Learn more